171 related articles for article (PubMed ID: 18725443)
1. In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.
Fenoll A; Aguilar L; Robledo O; Giménez MJ; Granizo JJ; Biek D; Tarragó D
Antimicrob Agents Chemother; 2008 Nov; 52(11):4209-10. PubMed ID: 18725443
[No Abstract] [Full Text] [Related]
2. Short-term bactericidal activity of amoxicillin and cefotaxime against penicillin-susceptible and -resistant pneumococcal strains: an in vitro pharmacodynamic simulation.
Fenoll A; Casal J; Giménez MJ; Jado I; Aguilar L
J Chemother; 2000 Apr; 12(2):124-8. PubMed ID: 10789550
[TBL] [Abstract][Full Text] [Related]
3. Drug-resistant Streptococcus pneumoniae spinal epidural abscess in a toddler.
Perez Mato S; Bégué CR; English MR; Bégué RE
Pediatr Infect Dis J; 2000 Jul; 19(7):664-6. PubMed ID: 10917231
[No Abstract] [Full Text] [Related]
4. Choice of an oral beta-lactam antibiotic for infections due to penicillin-resistant Streptococcus pneumoniae.
Goldstein FW
Scand J Infect Dis; 1997; 29(3):255-7. PubMed ID: 9255885
[TBL] [Abstract][Full Text] [Related]
5. Influence of penicillin/amoxicillin non-susceptibility on the activity of third-generation cephalosporins against Streptococcus pneumoniae.
Fenoll A; Giménez MJ; Robledo O; Aguilar L; Tarragó D; Granizo JJ; Martín-Herrero JE
Eur J Clin Microbiol Infect Dis; 2008 Jan; 27(1):75-80. PubMed ID: 17943330
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.
McGee L; Biek D; Ge Y; Klugman M; du Plessis M; Smith AM; Beall B; Whitney CG; Klugman KP
Antimicrob Agents Chemother; 2009 Feb; 53(2):552-6. PubMed ID: 19015339
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of oral cephalosporins against pediatric isolates of Streptococcus pneumoniae non-susceptible to penicillin, amoxicillin or erythromycin.
Fenoll A; Giménez MJ; Robledo O; Aguilar L; Tarragó D; Granizo JJ; Gimeno M; Coronel P
J Chemother; 2008 Apr; 20(2):175-9. PubMed ID: 18467242
[TBL] [Abstract][Full Text] [Related]
8. Predicting Oral Beta-lactam susceptibilities against Streptococcus pneumoniae.
Murphy ME; Powell E; Courter J; Mortensen JE
BMC Infect Dis; 2021 Jul; 21(1):679. PubMed ID: 34256734
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibilities of amoxycillin-non-susceptible and susceptible isolates among penicillin-non-susceptible Streptococcus pneumoniae.
Pérez-Trallero E; Marimón JM; Ercibengoa M; Giménez MJ; Coronel P; Aguilar L
Clin Microbiol Infect; 2007 Sep; 13(9):937-40. PubMed ID: 17617182
[TBL] [Abstract][Full Text] [Related]
10. Activities against Streptococcus pneumoniae of amoxicillin and cefotaxime at physiological concentrations: in vitro pharmacodynamic simulation.
Balcabao IP; Aguilar L; Martín M; García Y; Dal-Ré R; Prieto J
Antimicrob Agents Chemother; 1996 Dec; 40(12):2904-6. PubMed ID: 9124866
[TBL] [Abstract][Full Text] [Related]
11. Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
Jacobs MR; Good CE; Windau AR; Bajaksouzian S; Biek D; Critchley IA; Sader HS; Jones RN
Antimicrob Agents Chemother; 2010 Jun; 54(6):2716-9. PubMed ID: 20308374
[TBL] [Abstract][Full Text] [Related]
12. [Current status of pneumococcal resistance].
Roussel-Delvallez M
Presse Med; 1998 Sep; 27 Suppl 4():9-10. PubMed ID: 9798475
[No Abstract] [Full Text] [Related]
13. Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness.
Soriano F; Cafini F; Aguilar L; Tarragó D; Alou L; Giménez MJ; Gracia M; Ponte MC; Leu D; Pana M; Letowska I; Fenoll A
J Antimicrob Chemother; 2008 Dec; 62(6):1234-40. PubMed ID: 18799472
[TBL] [Abstract][Full Text] [Related]
14. Penicillin-resistant Streptococcus pneumoniae.
Hedge DD
S D J Med; 1996 Nov; 49(11):423-4. PubMed ID: 8973136
[No Abstract] [Full Text] [Related]
15. [Antimicrobial resistance of Streptococcus pneumoniae, 2003-2009].
Năstase E; Dorneanu O; Dorobăţ C
Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):536-41. PubMed ID: 21870753
[TBL] [Abstract][Full Text] [Related]
16. In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Verhaegen J; Verbist L
J Antimicrob Chemother; 1998 Mar; 41(3):381-5. PubMed ID: 9578165
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae in southwestern Japan and correlation of penicillin-binding protein 2b and 2x mutations in susceptibilities of penicillin G and cefotaxime.
Nagai K; Matsuo Y; Tsumura N; Sakata Y; Kato H
Diagn Microbiol Infect Dis; 2000 Jun; 37(2):107-13. PubMed ID: 10863105
[TBL] [Abstract][Full Text] [Related]
18. Streptococcus pneumoniae susceptible to benzylpenicillin but with reduced susceptibility to both cefotaxime and ceftriaxone.
Bell SM; Gatus BJ; Pham JN
Med J Aust; 1996 Feb; 164(3):188. PubMed ID: 8628145
[No Abstract] [Full Text] [Related]
19. Pharmacodynamic effects of amoxicillin versus cefotaxime against penicillin-susceptible and penicillin-resistant pneumococcal strains: a phase I study.
Aguilar L; Rosendo J; Balcabao IP; Martín M; Giménez MJ; Frías J; Prieto J
Antimicrob Agents Chemother; 1997 Jun; 41(6):1389-91. PubMed ID: 9174206
[TBL] [Abstract][Full Text] [Related]
20. Combination cefixime/amoxicillin against penicillin-resistant Streptococcus pneumoniae infection.
Matsumoto Y
Chemotherapy; 1998 Sep; 44 Suppl 1():6-9. PubMed ID: 9797416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
